<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01883caa a2200193   4500</leader>
  <controlfield tag="008">210629s9999    xx            000 0 und d</controlfield>
  <datafield tag="022" ind1=" " ind2=" ">
    <subfield code="a">1708-8186</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Niraj Kumar Singh</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2="0">
    <subfield code="a">Inter-frequency amplitude ratio of oVEMP for differentiating Meniere&#x2019;s disease from BPPV: clinical validation using a double-blind approach</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">21-28</subfield>
  </datafield>
  <datafield tag="490" ind1=" " ind2=" ">
    <subfield code="v">Volume 58  Issue 1</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Objective: The study aimed at examining the usefulness of inter-frequency amplitude ratio (IFAR) of ocular vestibular evoked myogenic potential (oVEMP) in identifying Meniere&#x2019;s disease (MD) and differentiating it from benign paroxysmal positional vertigo (BPPV).Design: A case-control design was used with a double blind approach. Phase 1 included 70 healthy individuals and 36 individuals each with MD and BPPV and Phase 2 included 20 individuals each with MD and BPPV. The age range of the participants in both phases was 15&#x2013;50 years. All participants underwent oVEMP testing using 500 and 1000&#x2009;Hz tone bursts and IFAR was obtained.Results: The results in phase 1 revealed significantly higher IFARs in Meniere&#x2019;s disease than BPPV and healthy individuals (p&#x2009;&lt;&#x2009;0.001). An optimum criterion point of IFAR &#x2265;1.11 for diagnosing MD was found which yielded 80% sensitivity and 98% specificity. The results in phase 2 demonstrated 85% correct identification of MD and 95% correct rejection of BPPV as non-MD.Conclusions: IFAR of oVEMP appears highly sensitive and specific parameter for identifying MD and a clinically valid tool for differentiating MD from BPPV.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Frequency-amplitude ratio, oVEMP, Meniere&#x2019;s disease, BPPV, double-blind study, clinical validation </subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Animesh Barman</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="a">International Journal of Audiology </subfield>
  </datafield>
  <datafield tag="856" ind1=" " ind2=" ">
    <subfield code="u">https://doi.org/10.1080/14992027.2018.1529440</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">FJAS</subfield>
    <subfield code="y">FJAS</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">17849</subfield>
    <subfield code="d">17849</subfield>
  </datafield>
</record>
